Root Financial Partners
KYMR icon

Root Financial Partners’s Kymera Therapeutics KYMR Stock Holding History

Root Financial Partners’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.5K Buy
+76
New +$8.71K ﹤0.01% 1992
2026
Q2 		– Sell
-80
Closed -$6.66K – 1923
2026
Q1 		$6.66K Sell
80
-4
-5% -$317 ﹤0.01% 1837
2025
Q4 		$6.54K Buy
84
+44
+110% +$2.97K ﹤0.01% 1673
2025
Q3 		$2.26K Buy
+40
New +$1.8K ﹤0.01% 1936

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Root Financial Partners's KYMR Position: Q3 2026 in Review

Root Financial Partners opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 76 shares worth $8.5K. The stake represents ﹤0.01% of the portfolio and ranks #1992 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in KYMR as recently as Q1 2026.

Root Financial Partners first reported a position in KYMR in Q3 2025 and has held it in 4 quarters since. 215 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Root Financial Partners held 76 shares of Kymera Therapeutics worth $8.5K as of Q3 2026.
  • Kymera Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Kymera Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1992 holding.
  • Root Financial Partners first reported a position in Kymera Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 215 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.